Abstract
The increase in migratory ability of pancreatic ductal adenocarcinoma cells is a key event in the development of metastasis to the lymph nodes and distant organs. Although the C-C motif chemokine receptor 7 (CCR7) and its ligand, C-C motif chemokine ligand 21 (CCL21), have been revealed to serve an important role in tumor migration, their precise roles and potential underlying mechanisms remain largely unknown. The present study revealed that overexpression of CCR7 significantly promoted BxPC-3 cell migration, accompanied by the induction of anoctamin 6 (ANO6) expression, indicating that ANO6 is a downstream target of CCR7 signaling. Furthermore, the level of phosphorylated extracellular signal-regulated kinase (ERK) was significantly increased in CCR7-overexpressing BxPC-3 cells, indicating that ERK may be a potential mediator of CCR7-regulated ANO6 expression in BxPC-3 cells. To characterize the receptor-mediated pathway, a specific ERK inhibitor, U0126, was used, which reduced BxPC-3 cell migration and the expression of ANO6. In summary, the results of the present study demonstrate that CCR7 promoted BxPC-3 cell migration by regulating ANO6 expression perhaps via activation of the ERK signaling pathway.
References
Mar 14, 2000·Immunity·A Zlotnik, O Yoshie
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 19, 2004·The New England Journal of Medicine·John P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
May 4, 2006·International Journal of Cancer. Journal International Du Cancer·Albert Zlotnik
Oct 4, 2006·Cancer Metastasis Reviews·A Ben-Baruch
May 13, 2008·Immunobiology·Sha WuGuanxin Shen
Jun 12, 2008·Oncology·Bunzo NakataKosei Hirakawa
Jul 9, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Jiang LiGuobin Wang
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Oct 25, 2011·International Journal of Cancer. Journal International Du Cancer·Jan SperveslageBence Sipos
Sep 15, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Helenisa Helena Oliveira-NetoAline Carvalho Batista
Nov 20, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Kalina SzteynEkaterina Shumilina
Jun 12, 2013·Pflügers Archiv : European journal of physiology·Karl KunzelmannJohan W M Heemskerk
Jun 14, 2013·Oncology Letters·Jinghui GuoShuncai Zhang
Jul 9, 2013·Pflügers Archiv : European journal of physiology·K S JacobsenA Schwab
Oct 12, 2013·Histopathology·Markku Miettinen
Apr 29, 2014·BMC Cancer·Tomoyuki IrinoYuko Kitagawa
Jun 11, 2014·PloS One·Mei-Lin SuWen-Chun Hung
Oct 2, 2014·International Journal of Oncology·Fa-Yu LiuChang-Fu Sun
Nov 19, 2014·BioMed Research International·Fa-Yu LiuChang-Fu Sun
Jan 13, 2015·Medical Oncology·Jianping ZhangYonggang Yang
Feb 1, 2015·Medical Oncology·Shaomei ChengXiangshan Yang
Mar 10, 2015·Molecular Cancer·Elena Tutunea-FatanPeeyush K Lala
Mar 24, 2015·PloS One·Miao MoXiong-Bing Zu
Jul 16, 2015·Oncotarget·Huiying MaChunmin Liang
Jul 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kexin LiRui Liu
Mar 27, 2016·Oncotarget·Li ShangMing-Rong Wang
Aug 10, 2016·PloS One·Lirong ZhangZhaoliang Su
Oct 26, 2016·Oncology Reports·Hani Al-ShareefMikihiko Kogo
Apr 26, 2017·Seminars in Cancer Biology·E GiovannettiG J Peters